Literature DB >> 25044210

Mechanical downsizing of a gadolinium(III)-based metal-organic framework for anticancer drug delivery.

Tanay Kundu1, Shouvik Mitra, Prasun Patra, Arunava Goswami, David Díaz Díaz, Rahul Banerjee.   

Abstract

A Gd(III) -based porous metal-organic framework (MOF), Gd-pDBI, has been synthesized using fluorescent linker pDBI (pDBI=(1,4-bis(5-carboxy-1H-benzimidazole-2-yl)benzene)), resulting in a three-dimensional interpenetrated structure with a one-dimensional open channel (1.9×1.2 nm) filled with hydrogen-bonded water assemblies. Gd-pDBI exhibits high thermal stability, porosity, excellent water stability, along with organic-solvent and mild acid and base stability with retention of crystallinity. Gd-pDBI was transformed to the nanoscale regime (ca. 140 nm) by mechanical grinding to yield MG-Gd-pDBI with excellent water dispersibility (>90 min), maintaining its porosity and crystallinity. In vitro and in vivo studies on MG-Gd-pDBI revealed its low blood toxicity and highest drug loading (12 wt %) of anticancer drug doxorubicin in MOFs reported to date with pH-responsive cancer-cell-specific drug release.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  ball-milling; doxorubicin; drug delivery; metal-organic frameworks; nanocarriers

Mesh:

Substances:

Year:  2014        PMID: 25044210     DOI: 10.1002/chem.201402244

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  12 in total

1.  Toxicity of nanoscale metal organic frameworks: a perspective.

Authors:  Muhammad Sajid
Journal:  Environ Sci Pollut Res Int       Date:  2016-06-14       Impact factor: 4.223

2.  Improvement in Thermal Stability of Sucralose by γ-Cyclodextrin Metal-Organic Frameworks.

Authors:  Nana Lv; Tao Guo; Botao Liu; Caifen Wang; Vikaramjeet Singh; Xiaonan Xu; Xue Li; Dawei Chen; Ruxandra Gref; Jiwen Zhang
Journal:  Pharm Res       Date:  2016-11-28       Impact factor: 4.200

Review 3.  Applications of Metal-Organic Frameworks as Drug Delivery Systems.

Authors:  Bianca Maranescu; Aurelia Visa
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

4.  Soft and Condensed Nanoparticles and Nanoformulations for Cancer Drug Delivery and Repurpose.

Authors:  Wen Yang; Hanitrarimalala Veroniaina; Xiaole Qi; Pengyu Chen; Feng Li; Pu Chun Ke
Journal:  Adv Ther (Weinh)       Date:  2019-10-16

5.  Activation performance and mechanism of a novel heterogeneous persulfate catalyst: Metal Organic Framework MIL-53(Fe) with FeII/FeIII mixed-valence coordinative unsaturated iron center.

Authors:  Mengjie Pu; Yongwen Ma; Jinquan Wan; Yan Wang; Jiumei Wang; Mark L Brusseau
Journal:  Catal Sci Technol       Date:  2017-02-16       Impact factor: 6.119

6.  High efficiency and long-term intracellular activity of an enzymatic nanofactory based on metal-organic frameworks.

Authors:  Xizhen Lian; Alfredo Erazo-Oliveras; Jean-Philippe Pellois; Hong-Cai Zhou
Journal:  Nat Commun       Date:  2017-12-12       Impact factor: 14.919

7.  Kinetic Analysis of the Uptake and Release of Fluorescein by Metal-Organic Framework Nanoparticles.

Authors:  Tobias Preiß; Andreas Zimpel; Stefan Wuttke; Joachim O Rädler
Journal:  Materials (Basel)       Date:  2017-02-22       Impact factor: 3.623

8.  Theranostic metal-organic framework core-shell composites for magnetic resonance imaging and drug delivery.

Authors:  Huai-Xin Zhao; Quan Zou; Shao-Kai Sun; Chunshui Yu; Xuejun Zhang; Rui-Jun Li; Yan-Yan Fu
Journal:  Chem Sci       Date:  2016-04-26       Impact factor: 9.825

Review 9.  Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review.

Authors:  Mihad Ibrahim; Waad H Abuwatfa; Nahid S Awad; Rana Sabouni; Ghaleb A Husseini
Journal:  Pharmaceutics       Date:  2022-01-21       Impact factor: 6.321

Review 10.  Biomedical Applications of Metal-Organic Frameworks for Disease Diagnosis and Drug Delivery: A Review.

Authors:  Miral Al Sharabati; Rana Sabouni; Ghaleb A Husseini
Journal:  Nanomaterials (Basel)       Date:  2022-01-16       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.